I spent the last few weeks doing something unusual: instead of studying one cancer technology deeply, I mapped five of them side by side — radioisotope theranostics, bacteriophages, DNA-origami nanorobots, bacteria microrobots, and macrophage engineering — and asked what engineering logic they had independently converged on. The result surprised me enough that I wanted to share it.
The pattern nobody talks about
Every one of these fields is trying to solve the same problem: chemotherapy hits the whole body, so how do you make the killing conditional on location? And independently, three unrelated labs reinvented the same answer — pH-gated activation. Tumors sit around pH 6.5 while healthy tissue is 7.4, and that tiny chemical difference became a trigger.
When three fields that never talk to each other invent the same trick, that's not coincidence. That's a validated pattern.
Where TRIZ comes in
Running these through TRIZ contradiction analysis, the pairings got interesting. The big one: potency vs. precision. That led me to two original combinations that, as far as I could find, nobody is pursuing:
RadioPhage Origami Capsule. A magnetotactic bacterium carrying a DNA-origami capsule chelated to a radioisotope. The capsule stays sealed until tumor pH unfolds it.
CD47-Blocking PhageCloak. One phage capsid displaying a tumor-receptor ligand and a peptide that blocks the cancer cell's "don't-eat-me" CD47 signal, so the patient's own macrophages do the killing.
The honest part
Both ideas are conceptual — TRL 1 or 2. No experiments, no data, and I want to be explicit about that. This is ideation, not a lab protocol. But the method — extract patterns from sourced literature, run them through contradiction analysis, recombine — is a machine for generating inventable ideas.
Shivam Kumar is an AI researcher and founder of VisionQuantech, working on recursive pattern-combination methods for algorithm and architecture discovery.
Top comments (0)